Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:39:15 EDT Fri 04 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:ONWRY - ONWARD MEDICAL NV SPON ADS EACH REP 1 ORD - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ONWRY - Qnot subscribed2.982+0.0822.80.6222.982  2.982  2.9827.13  2.5215:35:3901:3015 min RT 2¢

Recent Trades - All 2 today
Time ETExPriceChangeVolume
15:35:39Q2.9820.082275
15:31:13Q2.9820.082275
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-09-04 01:30U:ONWRYNews ReleaseONWARD Medical to Announce First-Half 2026 Results on September 9, 2026
2026-09-03 01:30U:ONWRYNews ReleaseONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury
2026-05-26 01:30U:ONWRYNews ReleaseONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones
2026-05-19 01:30U:ONWRYNews ReleaseONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026
2026-05-13 11:57U:ONWRYNews ReleaseONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders
2026-04-01 02:45U:ONWRYNews ReleaseONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions
2026-03-31 01:30U:ONWRYNews ReleaseONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones
2026-03-23 02:30U:ONWRYNews ReleaseONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update
2026-02-04 01:30U:ONWRYNews ReleaseONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury
2026-01-23 01:30U:ONWRYNews ReleaseONWARD Medical Appoints Ali Kiboro as Chief Financial Officer
2026-01-22 01:30U:ONWRYNews ReleaseONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement
2025-11-24 01:30U:ONWRYNews ReleaseONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
2025-11-17 01:30U:ONWRYNews ReleaseONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
2025-10-13 01:30U:ONWRYNews ReleaseONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
2025-10-08 01:30U:ONWRYNews ReleasePortzamparc - BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
2025-09-18 01:30U:ONWRYNews ReleaseConcurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
2025-09-08 02:45U:ONWRYNews ReleaseONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe